Lunit
Developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology to solve the most critical issues in cancer care. Learn more
Launch date
Employees
Market cap
AUD1.5b
Enterprise valuation
AUD1.5b (Public information from Sep 2024)
Share price
KRW41900 328130.KQ
Company register number 3148650626
Seoul South Korea (HQ)
Authorizing premium user...